Cancer Crosslinks
  • Home
  • EVENTS
    • 2023
  • GALLERY
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
  • Organizers
  • 2023 Presentations

CANCER CROSSLINKS 2016

Cancer Crosslinks 2016

The Transversal Impact of New Treatments in Oncology and Hematology:
Tumor Microenvironment, Novel Concepts, Combinations and Study Design

Event 2016 - Speakers & Topics

Gordon J. Freeman, Division of Hematologic Malignancies, Department of Medical Oncology; Dana-Farber Cancer Institute & Harvard Medical School, Boston, USA
  • PD-1 Cancer Immunotherapy

Åslaug Helland, Senior Oncologist, Dept. of Oncology, Oslo University Hospital and Group leader, Institute for Cancer Research Oslo University Hospital
  • Case Study: Immunotherapy in NSCLC
Alexander Fosså, Senior Oncologist, Dept. of Oncology, Oslo University Hospital 
  • Case Study: PD-1 in Lymphoma

Renier Brentjens,  MD, PhD; Chief, Cellular Therapeutics Center & Associate Professor Memorial Sloan-Kettering Cancer Center; New York, USA
  • CAR T-cell Treatment of B-Cell Malignancies – With an Overview of Current Treatment Options in Leukemia

Stefani Spranger, Department of Pathology, The Ben May Department for Cancer Research, University of Chicago, USA
  • The Role of the T cell-inflamed and non-T cell-inflamed Tumor Microenvironment for Immunotherapy

A complete program for Cancer Crosslinks 2016 may be downloaded HERE.

Event 2016 - Sponsors

Picture
Picture

The Cancer Crosslinks series is organized by Oslo Cancer Cluster.  


  • Home
  • EVENTS
    • 2023
  • GALLERY
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
  • Organizers
  • 2023 Presentations